In abdominoplasty, cebranopadol increased the proportion of patients requiring no opioid rescue medication versus placebo, ...

A $50,000-per-dose threshold for clinician-administered drugs can standardize high-cost identification, while allowing ...

Michael Chancley Jr.’s personal experience with PrEP informs his work at PrEP4All as he advocates for expanded access and ...

The pharmaceutical industry is entering an era of mega-blockbusters, drugs with annual sales of $10 billion or more, that ...

Frequent CGM use ties to bigger A1c drops in type 2 diabetes, even across GLP-1, SGLT2, and insulin regimens. In this episode ...

A high-touch specialty pharmacy program that combines pharmacist support, telehealth and value-based care reduced medical ...

The ACA individual exchange exit is positioned as a strategic de-emphasis of a shrinking line, with no 2026 network changes ...

The "direct-to" channel was a hot topic at the Asembia specialty pharmacy meeting this week in Las Vegas. The drug supply ...

Health system specialty pharmacy programs are expanding beyond traditional roles to support value-based care, according to a ...

Cell and gene therapies are currently niche products, even within specialty pharmacy, drugs that, by most definitions, are ...

National Priority Vouchers aim to shorten FDA review from ~10–12 months to ~1–2 months using collaborative multidisciplinary ...

Attendance approaches 10,000 with extensive corporate representation, underscoring Asembia’s role as a central convening ...